Publicaciones (78) Publicaciones de JOSE ANTONIO RODRIGUEZ PEREZ

2023

  1. High Throughput Fluorescence-Based In Vitro Experimental Platform for the Identification of Effective Therapies to Overcome Tumour Microenvironment-Mediated Drug Resistance in AML

    Cancers, Vol. 15, Núm. 7

2022

  1. MARK4ren interakzioak USP21 deubikuitinasaren kokapen azpizelular dinamikoa erregulatzen du

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 42, pp. 193-206

2021

  1. A proteomic approach for systematic mapping of substrates of human deubiquitinating enzymes

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

  2. Konpartimentu-espezifikoko gertuko biotinilazioa: XPO1en esportazio-kargoak identifikatzeko hurbilketa berria

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 41, pp. 151-169

  3. LUZP1 Controls Cell Division, Migration and Invasion Through Regulation of the Actin Cytoskeleton

    Frontiers in Cell and Developmental Biology, Vol. 9

  4. The dystrophia myotonica WD repeat-containing protein DMWD and WDR20 differentially regulate USP12 deubiquitinase

    FEBS Journal, Vol. 288, Núm. 20, pp. 5943-5963

2020

  1. Nucleophosmin, a multifunctional nucleolar organizer with a role in DNA repair

    Biochimica et Biophysica Acta - Proteins and Proteomics, Vol. 1868, Núm. 12

  2. SPANX-A/D protein subfamily plays a key role in nuclear organisation, metabolism and flagellar motility of human spermatozoa

    Scientific Reports, Vol. 10, Núm. 1

  3. Using a Simple Cellular Assay to Map NES Motifs in Cancer-Related Proteins, Gain Insight into CRM1-Mediated NES Export, and Search for NES-Harboring Micropeptides

    International journal of molecular sciences, Vol. 21, Núm. 17

  4. XPO1en bidezko garraio nukleozitoplasmikoa: oinarrizko mekanismoak eta hurbilketa esperimentalak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 37, pp. 221-239

2018

  1. Hitting a moving target: inhibition of the nuclear export receptor XPO1/CRM1 as a therapeutic approach in cancer

    CANCER DRUG RESISTANCE, Vol. 1, Núm. 3, pp. 139-163

  2. Truncated SALL1 Impedes Primary Cilia Function in Townes-Brocks Syndrome

    American Journal of Human Genetics, Vol. 102, Núm. 2, pp. 249-265

2017

  1. Conformational stabilization as a strategy to prevent nucleophosmin mislocalization in leukemia

    Scientific Reports, Vol. 7, Núm. 1

  2. Therapeutic effects of XPO1 inhibition in thymic epithelial tumors

    Cancer Research, Vol. 77, Núm. 20, pp. 5614-5627

2016

  1. A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K

    Cellular and Molecular Life Sciences, Vol. 73, Núm. 24, pp. 4685-4699

  2. Description of USP12 nuclear export sequence

    Proceedings of the National Academy of Sciences of the United States of America

  3. Mutations in the 'Fingers' subdomain of the deubiquitinase USP1 modulate its function and activity

    The FEBS journal, Vol. 283, Núm. 5, pp. 929-946

  4. Proteome-wide search for functional motifs altered in tumors: Prediction of nuclear export signals inactivated by cancer-related mutations

    Scientific Reports, Vol. 6

2015

  1. Leukemia-associated mutations in nucleophosmin alter recognition by CRM1: Molecular basis of aberrant transport

    PLoS ONE, Vol. 10, Núm. 6

  2. Molecular pathways: Anticancer activity by inhibition of nucleocytoplasmic shuttling

    Clinical Cancer Research, Vol. 21, Núm. 20, pp. 4508-4513